Balzarini, J., Pérez-Pérez, M. J., Vélazquez, S., San-Félix, A., Camarasa, M. J., De Clercq, E., & Karlsson, A. (1995). Suppression of the breakthrough of human immunodeficiency virus type 1 (HIV-1) in cell culture by thiocarboxanilide derivatives when used individually or in combination with other HIV-1-specific inhibitors (i.e., TSAO derivatives).

Balzarini, J., M J. Pérez-Pérez, S. Vélazquez, A. San-Félix, M J. Camarasa, E. De Clercq, a A. Karlsson. Suppression of the Breakthrough of Human Immunodeficiency Virus Type 1 (HIV-1) in Cell Culture By Thiocarboxanilide Derivatives When Used Individually or in Combination With Other HIV-1-specific Inhibitors (i.e., TSAO Derivatives). 1995.

Balzarini, J., et al. Suppression of the Breakthrough of Human Immunodeficiency Virus Type 1 (HIV-1) in Cell Culture By Thiocarboxanilide Derivatives When Used Individually or in Combination With Other HIV-1-specific Inhibitors (i.e., TSAO Derivatives). 1995.